Literature DB >> 31966634

FTL: a novel predictor in gastric cancer.

Lixiang Zhang1, Zhangming Chen1, Aman Xu1.   

Abstract

BACKGROUND: Ferritin light chain (FTL) is a functionally distinct composition of ferritin, which is over-expressed and play an important role in multiple human malignancies.
METHODS: Matched normal and cancerous tissues in 60 gastric cancer (GC) patients were detected for FTL expression using immunohistochemistry staining. The relationship betweent FTL expression and clinicopathological features was analyzed by chi-square test, and the Kaplan-Meier curves and Cox regression analyses were used to calculate the overall survival (OS) characteristics and recurrence-free survival (RFS).
RESULTS: FTL protein was significantly higher in GC tissues than adjacent tissues. Further, FTL expression was not correlative with gender, age, tumor size, tumor location, CEA and AFP level (P>0.05). However, the associations between FTL expression and depth of tumor invasion (P=0.014), differentiation grade (P=0.001), lymph node metastasis (P<0.001) and TNM stage (P<0.001) were significant. Additionally, patients of GC with low FTL expression had longer OS (P=0.019) and RFS (P=0.011), and FTL was an independent prognostic factor for both RFS and OS.
CONCLUSIONS: FTL was an independent risk factor for both RFS and OS, indicating that FTL could be considered as a prognostic factor for GC patients. IJCEP
Copyright © 2017.

Entities:  

Keywords:  Ferritin light chain; gastric cancer; overall survival; recurrence-free survival

Year:  2017        PMID: 31966634      PMCID: PMC6965267     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  2 in total

1.  Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver Cancer.

Authors:  Pengfei Ren; Keyan Wang; Jie Ma; Xiaoqin Cao; Jiuzhou Zhao; Chengzhi Zhao; Yongjun Guo; Hua Ye
Journal:  J Hepatocell Carcinoma       Date:  2022-03-29

2.  Downregulation of FTL decreases proliferation of malignant mesothelioma cells by inducing G1 cell cycle arrest.

Authors:  Takahiro Kambara; Vishwa Jeet Amatya; Kei Kushitani; Yutaro Fujii; Ihiro Endo; Yukio Takeshima
Journal:  Oncol Lett       Date:  2022-04-13       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.